002223.SZ
鱼跃医疗
SZSE · Healthcare · C 制造业 · CN
CNY 25.99
+2.04%Year over year
Reported trailing growth
- Revenue
- +1.5%
- EBITDA
- —
- EBIT
- -22.6%
- EPS
- -27.6%
- Free cash flow
- -20.7%
- Operating cash flow
- -19.8%
Forward estimates
Based on analyst estimates
- Revenue
- +14.4%
- EBITDA
- -20.9%
- EPS
- -13.3%
Three-year CAGR
- Revenue
- +3.9%
- EBITDA
- -1.4%
- EBIT
- -2.6%
- Net income
- -2.4%
- EPS
- -2.8%
- Free cash flow
- -10.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026